Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Annales D'Endocrinologie|December 29, 2024
Tatton-Brown-Rahman syndrome: A new multiple endocrine neoplasia syndrome with intellectual disability?Lauriane Le Collen, Théo Charnay, Sang Ly, et al.
European Journal of Endocrinology|April 15, 2004
Thyrotoxic adenoma followed by atypical hyperthyroidism due to struma ovarii: clinical and genetic studiesAntonio Ciccarelli, Hernan Valdes-Socin, Jasmine Parma, et al.
Archives of Endocrinology and Metabolism|October 5, 2017
Use of cinacalcet and sunitinib to treat hypercalcaemia due to a pancreatic neuroendocrine tumorHernan Valdes-Socin, Matilde Rubio Almanza, Mariana Tomé Fernández-Ladreda, et al.
The Journal of Clinical Endocrinology and Metabolism|November 9, 2004
Long-term outcome of patients with acromegaly and congestive heart failureHélène Bihan, Consuelo Espinosa, Hernan Valdes-Socin, et al.
Neuroradiology|April 8, 2015
Intensity of prolactinoma on T2-weighted magnetic resonance imaging: towards another gender differenceJulie Kreutz, Laurent Vroonen, Francoise Cattin, et al.
Genome Medicine|September 13, 2024
Chromatin conformation capture in the clinic: 4C-seq/HiC distinguishes pathogenic from neutral duplications at the GPR101 locusAdrian F Daly, Leslie A Dunnington, David F Rodriguez-Buritica, et al.
European Journal of Endocrinology|March 15, 2005
Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogsPatrick Petrossians, Liliane Borges-Martins, Consuelo Espinoza, et al.
Endocrine|August 20, 2017
Effect of AP102, a subtype 2 and 5 specific somatostatin analog, on glucose metabolism in ratsErika Tarasco, Petra Seebeck, Svende Pfundstein, et al.
The Journal of Clinical Endocrinology and Metabolism|February 12, 2002
Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter studyBruno Vergès, Françoise Boureille, Pierre Goudet, et al.
International Journal of Cancer|August 9, 2008
Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxelMaria A Tichomirowa, Marily Theodoropoulou, Adrian F Daly, et al.
Pageof 17